Arja Jukkola-Vuorinen
Ratings
0
Nobody has rated this yet. Be the first!
Works
4
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
A recurrent mutation in PALB2 in Finnish cancer families
Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
